To further assess the role of folate metabolism in differentiation of CML cells, we cultured patient-derived CML CD34+ cells with low concentration (3U/ml) of erythropoietin, required to sensitise cells to erythroid commitment. The gene discussed is EPO; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.